title: Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acids.
abstract: The effects of hyperinsulinemia and hyperaminoacidemia on glucose and amino acid metabolism were examined in 16 control and 13 chronic renal failure (CRF) patients under two conditions: 1) euglycemic hyperinsulinemia and 2) amino acid infusion. All studies were performed with continuous indirect calorimetry and [1-14C]leucine infusion. In CRF patients insulin-mediated whole body glucose metabolism was reduced by 35% (4.41 +/- 0.50 vs. 6.76 +/- 0.73 mg.kg-1.min-1, P less than 0.01), primarily due to a decrease in nonoxidative glucose disposal (1.70 +/- 0.70 vs. 4.32 +/- 0.60 mg.kg-1.min-1, P less than 0.01); glucose oxidation was similar in both groups. In the postabsorptive state total leucine turnover (1.56 +/- 0.06 vs. 1.75 +/- 0.06), leucine oxidation (0.25 +/- 0.01 vs. 0.30 +/- 0.01), and nonoxidative leucine disposal (1.29 +/- 0.06 vs. 1.40 +/- 0.07 mumol.kg-1.min-1) were reduced in CRF vs. control subjects (all P less than 0.05). In response to hyperinsulinemia, endogenous leucine flux (index of proteolysis), leucine oxidation, nonoxidative leucine disposal (NOLD) (index of protein synthesis), and net leucine flux into protein were similar in CRF and control subjects. In contrast, the ability of hyperaminoacidemia to enhance NOLD (1.54 +/- 0.11 vs. 2.10 +/- 0.10 mumol.kg-1.min-1, P less than 0.01) and net leucine balance (0.27 +/- 0.05 vs. 0.41 +/- 0.05, P less than 0.05) was reduced in CRF patients.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Nephrology, University of Texas Health Science Center, San Antonio.
authors.forename: P
authors.initials: P
authors.lastname: Castellino
authors.forename: A
authors.initials: A
authors.lastname: Solini
authors.forename: L
authors.initials: L
authors.lastname: Luzi
authors.forename: J G
authors.initials: JG
authors.lastname: Barr
authors.forename: D J
authors.initials: DJ
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Petrides
authors.forename: M
authors.initials: M
authors.lastname: Giordano
authors.forename: C
authors.initials: C
authors.lastname: Carroll
authors.forename: R A
authors.initials: RA
authors.lastname: DeFronzo
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000378:metabolism* / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D005947:Glucose / Q000378:metabolism*; D006728:Hormones / Q000097:blood; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007651:Keto Acids / Q000097:blood; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D007930:Leucine / Q000097:blood / Q000378:metabolism; D050356:Lipid Metabolism; D008875:Middle Aged; D010084:Oxidation-Reduction; D011506:Proteins / Q000378:metabolism
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D006728:Hormones; D007328:Insulin; D007651:Keto Acids; D011506:Proteins; C013082:alpha-ketoisocaproic acid; D007930:Leucine; D005947:Glucose